{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:54:00Z","timestamp":1785578040861,"version":"3.56.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA293908"],"award-info":[{"award-number":["R01CA293908"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA276525"],"award-info":[{"award-number":["R01CA276525"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA236702"],"award-info":[{"award-number":["R01CA236702"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K00CA274651"],"award-info":[{"award-number":["K00CA274651"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41565-026-02170-9","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T09:02:54Z","timestamp":1781254974000},"page":"892-903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Activating a B cell immune response regresses immunologically cold tumours"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4535-3497","authenticated-orcid":false,"given":"Heena","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9857-1025","authenticated-orcid":false,"given":"Nimish","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-0837","authenticated-orcid":false,"given":"Aniruddha","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5946-2846","authenticated-orcid":false,"given":"Arindam","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8249-095X","authenticated-orcid":false,"given":"Sanghamitra","family":"Mylavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4035-0027","authenticated-orcid":false,"given":"Ivan S.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmoy","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3366-4851","authenticated-orcid":false,"given":"Binayak","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-2202","authenticated-orcid":false,"given":"Ashish","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0814-2989","authenticated-orcid":false,"given":"Vinay S.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9777-6221","authenticated-orcid":false,"given":"Lipika","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4885-1157","authenticated-orcid":false,"given":"Aditya","family":"Bardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fahrner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermanno","family":"Gherardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3112-4774","authenticated-orcid":false,"given":"Raghunath","family":"Mashelkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Soon-Shiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3923-9732","authenticated-orcid":false,"given":"Hae Lin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-5052","authenticated-orcid":false,"given":"Shiladitya","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2170_CR1","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.cell.2018.11.006","volume":"175","author":"J Wolchok","year":"2018","unstructured":"Wolchok, J. Putting the immunologic brakes on cancer. Cell 175, 1452\u20131454 (2018).","journal-title":"Cell"},{"key":"2170_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","volume":"10","author":"P Bonaventura","year":"2019","unstructured":"Bonaventura, P. et al. Cold tumors: a therapeutic challenge for immunotherapy. Front. Immunol. 10, 168\u2013168 (2019).","journal-title":"Front. Immunol."},{"key":"2170_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon, J. & Bruni, D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 18, 197\u2013218 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2170_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.cell.2017.08.031","volume":"170","author":"JBAG Haanen","year":"2017","unstructured":"Haanen, J. B. A. G. Converting cold into hot tumors by combining immunotherapies. Cell 170, 1055\u20131056 (2017).","journal-title":"Cell"},{"key":"2170_CR5","doi-asserted-by":"publisher","first-page":"E2104","DOI":"10.1073\/pnas.1603455113","volume":"113","author":"A Kulkarni","year":"2016","unstructured":"Kulkarni, A. et al. Reporter nanoparticle that monitors its anticancer efficacy in real time. Proc. Natl Acad. Sci. USA 113, E2104\u2013E2113 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2170_CR6","first-page":"987","volume":"54","author":"A Gabizon","year":"1994","unstructured":"Gabizon, A. et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 54, 987\u2013992 (1994).","journal-title":"Cancer Res."},{"key":"2170_CR7","unstructured":"Sengupta, S. et al. Lipid-based platinum compounds and nanoparticles. US patent 10,730,899 B2 (2020)."},{"key":"2170_CR8","doi-asserted-by":"publisher","first-page":"075103","DOI":"10.1088\/0957-4484\/23\/7\/075103","volume":"23","author":"A Paraskar","year":"2012","unstructured":"Paraskar, A., Soni, S., Roy, B., Papa, A. L. & Sengupta, S. Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy. Nanotechnology 23, 075103 (2012).","journal-title":"Nanotechnology"},{"key":"2170_CR9","doi-asserted-by":"publisher","first-page":"12435","DOI":"10.1073\/pnas.1007026107","volume":"107","author":"AS Paraskar","year":"2010","unstructured":"Paraskar, A. S. et al. Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy. Proc. Natl Acad. Sci. USA 107, 12435\u201312440 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2170_CR10","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.1073\/pnas.1203129109","volume":"109","author":"P Sengupta","year":"2012","unstructured":"Sengupta, P. et al. Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity. Proc. Natl Acad. Sci. USA 109, 11294\u201311299 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2170_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","volume":"179","author":"DP Hollern","year":"2019","unstructured":"Hollern, D. P. et al. B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell 179, 1191\u20131206.e1121 (2019).","journal-title":"Cell"},{"key":"2170_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink, B. A. et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577, 549\u2013555 (2020).","journal-title":"Nature"},{"key":"2170_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez, F. et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577, 556\u2013560 (2020).","journal-title":"Nature"},{"key":"2170_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1593\/neo.11024","volume":"13","author":"M Candolfi","year":"2011","unstructured":"Candolfi, M. et al. B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory\/ conditionally cytotoxic therapy for glioblastoma. Neoplasia 13, 947\u2013960 (2011).","journal-title":"Neoplasia"},{"key":"2170_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12160-2","volume":"10","author":"J Griss","year":"2019","unstructured":"Griss, J. et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat. Commun. 10, 4186 (2019).","journal-title":"Nat. Commun."},{"key":"2170_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","volume":"20","author":"GV Sharonov","year":"2020","unstructured":"Sharonov, G. V., Serebrovskaya, E. O., Yuzhakova, D. V., Britanova, O. V. & Chudakov, D. M. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat. Rev. Immunol. 20, 294\u2013307 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2170_CR17","doi-asserted-by":"publisher","unstructured":"Bod, L. et al. B-cell-specific checkpoint molecules that regulate anti-tumour immunity. Nature https:\/\/doi.org\/10.1038\/s41586-023-06231-0 (2023).","DOI":"10.1038\/s41586-023-06231-0"},{"key":"2170_CR18","doi-asserted-by":"publisher","unstructured":"Wieland, A. et al. Defining HPV-specific B cell responses in patients with head and neck cancer. Nature https:\/\/doi.org\/10.1038\/s41586-020-2931-3 (2020).","DOI":"10.1038\/s41586-020-2931-3"},{"key":"2170_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41586-022-05668-z","volume":"614","author":"V Despic","year":"2023","unstructured":"Despic, V. & Jaffrey, S. R. mRNA ageing shapes the Cap2 methylome in mammalian mRNA. Nature 614, 358\u2013366 (2023).","journal-title":"Nature"},{"key":"2170_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/377649a0","volume":"377","author":"PM Takahara","year":"1995","unstructured":"Takahara, P. M., Rosenzweig, A. C., Frederick, C. A. & Lippard, S. J. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature 377, 649\u2013652 (1995).","journal-title":"Nature"},{"key":"2170_CR21","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1021\/acsnano.6b00241","volume":"10","author":"A Kulkarni","year":"2016","unstructured":"Kulkarni, A. et al. Algorithm for designing nanoscale supramolecular therapeutics with increased anticancer efficacy. ACS Nano 10, 8154\u20138168 (2016).","journal-title":"ACS Nano"},{"key":"2170_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41551-018-0254-6","volume":"2","author":"A Kulkarni","year":"2018","unstructured":"Kulkarni, A. et al. A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer. Nat. Biomed. Eng. 2, 589\u2013599 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"2170_CR23","doi-asserted-by":"publisher","first-page":"11774","DOI":"10.1073\/pnas.1410626111","volume":"111","author":"K Kim","year":"2014","unstructured":"Kim, K. et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells. Proc. Natl Acad. Sci. USA 111, 11774\u201311779 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2170_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101405","volume":"20","author":"T Rupp","year":"2022","unstructured":"Rupp, T. et al. Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response. Transl. Oncol. 20, 101405 (2022).","journal-title":"Transl. Oncol."},{"key":"2170_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","volume":"31","author":"G Kroemer","year":"2013","unstructured":"Kroemer, G., Galluzzi, L., Kepp, O. & Zitvogel, L. Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31, 51\u201372 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"2170_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1200\/JCO.2009.23.7370","volume":"28","author":"C Denkert","year":"2009","unstructured":"Denkert, C. et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J. Clin. Oncol. 28, 105\u2013113 (2009).","journal-title":"J. Clin. Oncol."},{"key":"2170_CR27","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-11-2210","volume":"18","author":"M Schmidt","year":"2012","unstructured":"Schmidt, M. et al. A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin \u03ba C as a compatible prognostic marker in human solid tumors. Clin. Cancer Res. 18, 2695\u20132703 (2012).","journal-title":"Clin. Cancer Res."},{"key":"2170_CR28","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria, A., Madrigal, J.A. & Saudem ont, A. B cell regulation in cancer and anti-tumor immunity. Cell Mol. Immunol. 14, 662\u2013674 (2017).","journal-title":"Cell Mol. Immunol."},{"key":"2170_CR29","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.4049\/jimmunol.179.10.6808","volume":"179","author":"D Bhattacharya","year":"2007","unstructured":"Bhattacharya, D. et al. Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation. J. Immunol. 179, 6808\u20136819 (2007).","journal-title":"J. Immunol."},{"key":"2170_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22300-2","volume":"12","author":"Q Hu","year":"2021","unstructured":"Hu, Q. et al. Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling. Nat. Commun. 12, 2186 (2021).","journal-title":"Nat. Commun."},{"key":"2170_CR31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1365-2567.2006.02436.x","volume":"119","author":"EA Clutterbuck","year":"2006","unstructured":"Clutterbuck, E. A. et al. The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine. Immunology 119, 328\u2013337 (2006).","journal-title":"Immunology"},{"key":"2170_CR32","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.0803773","volume":"183","author":"Q Li","year":"2009","unstructured":"Li, Q., Teitz-Tennenbaum, S., Donald, E. J., Li, M. & Chang, A. E. In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy. J. Immunol. 183, 3195\u20133203 (2009).","journal-title":"J. Immunol."},{"key":"2170_CR33","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/intimm\/5.6.647","volume":"5","author":"J Chen","year":"1993","unstructured":"Chen, J. et al. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5, 647\u2013656 (1993).","journal-title":"Int. Immunol."},{"key":"2170_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fonc.2018.00016","volume":"8","author":"S Mylavarapu","year":"2018","unstructured":"Mylavarapu, S., Das, A. & Roy, M. Role of BRCA mutations in the modulation of response to platinum therapy. Front. Oncol. 8, 16 (2018).","journal-title":"Front. Oncol."},{"key":"2170_CR35","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2009.356","volume":"29","author":"A Tesniere","year":"2010","unstructured":"Tesniere, A. et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 29, 482\u2013491 (2010).","journal-title":"Oncogene"},{"key":"2170_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.272.5260.408","volume":"272","author":"J Taunton","year":"1996","unstructured":"Taunton, J., Hassig, C. A. & Schreiber, S. L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408\u2013411 (1996).","journal-title":"Science"},{"key":"2170_CR37","doi-asserted-by":"publisher","unstructured":"Free, R. B., Hazelwood, L. A. & Sibley, D. R. Identifying novel protein-protein interactions using co-immunoprecipitation and mass spectroscopy. Curr. Protoc. Neurosci. https:\/\/doi.org\/10.1002\/0471142301.ns0528s46 (2009).","DOI":"10.1002\/0471142301.ns0528s46"},{"key":"2170_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature09489","volume":"468","author":"S Daffis","year":"2010","unstructured":"Daffis, S. et al. 2\u2032-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468, 452\u2013456 (2010).","journal-title":"Nature"},{"key":"2170_CR39","doi-asserted-by":"publisher","first-page":"E2106","DOI":"10.1073\/pnas.1612444114","volume":"114","author":"YM Abbas","year":"2017","unstructured":"Abbas, Y. M. et al. Structure of human IFIT1 with capped RNA reveals adaptable mRNA binding and mechanisms for sensing N1 and N2 ribose 2\u2032-O methylations. Proc. Natl Acad. Sci. USA 114, E2106\u2013E2115 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2170_CR40","doi-asserted-by":"publisher","unstructured":"Corso, G. et al. Deep confident steps to new pockets: strategies for docking generalization. Preprint at https:\/\/doi.org\/10.48550\/arXiv.2402.18396 (2024).","DOI":"10.48550\/arXiv.2402.18396"},{"key":"2170_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4004","volume":"5","author":"M Smietanski","year":"2014","unstructured":"Smietanski, M. et al. Structural analysis of human 2\u2032-O-ribose methyltransferases involved in mRNA cap structure formation. Nat. Commun. 5, 3004 (2014).","journal-title":"Nat. Commun."},{"key":"2170_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/gene.2011.21","volume":"12","author":"S Ning","year":"2011","unstructured":"Ning, S., Pagano, J. S. & Barber, G. N. IRF7: activation, regulation, modification and function. Genes Immun. 12, 399\u2013414 (2011).","journal-title":"Genes Immun."},{"key":"2170_CR43","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cytogfr.2014.05.002","volume":"25","author":"MS Diamond","year":"2014","unstructured":"Diamond, M. S. IFIT1: a dual sensor and effector molecule that detects non-2\u2032-O methylated viral RNA and inhibits its translation. Cytokine Growth Factor Rev. 25, 543\u2013550 (2014).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2170_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri3344","volume":"1","author":"MS Diamond","year":"2013","unstructured":"Diamond, M.S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 1, 46\u201357 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"2170_CR45","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1261\/rna.080011.124","volume":"30","author":"J Geng","year":"2024","unstructured":"Geng, J. et al. Cap-related modifications of RNA regulate binding to IFIT proteins. RNA 30, 1292\u20131305 (2024).","journal-title":"RNA"},{"key":"2170_CR46","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1128\/JVI.02744-14","volume":"89","author":"V Fensterl","year":"2015","unstructured":"Fensterl, V. & Sen, G. C. Interferon-induced Ifit proteins: their role in viral pathogenesis. J. Virol. 89, 2462 (2015).","journal-title":"J. Virol."},{"key":"2170_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.105","volume":"57","author":"EJ Mendoza","year":"2020","unstructured":"Mendoza, E. J., Manguiat, K., Wood, H. & Drebot, M. Two detailed plaque assay protocols for the quantification of infectious SARS-CoV-2. Curr. Protoc. Microbiol. 57, ecpmc105 (2020).","journal-title":"Curr. Protoc. Microbiol."},{"key":"2170_CR48","doi-asserted-by":"publisher","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","volume":"50","author":"G Tang","year":"2022","unstructured":"Tang, G., Cho, M. & Wang, X. OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer. Nucleic Acids Res. 50, D1334\u2013D1339 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2170_CR49","doi-asserted-by":"publisher","first-page":"D1391","DOI":"10.1093\/nar\/gkab804","volume":"50","author":"Z Zeng","year":"2022","unstructured":"Zeng, Z. et al. TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Res. 50, D1391\u2013D1397 (2022).","journal-title":"Nucleic Acids Res."},{"key":"2170_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001764","volume":"9","author":"VO Pimentel","year":"2021","unstructured":"Pimentel, V. O. et al. Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19\u2013IL2 cures poorly immunogenic tumors when combined with radiotherapy. J. Immunother. Cancer 9, e001764 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"2170_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04130-7","volume":"22","author":"HE Miller","year":"2021","unstructured":"Miller, H. E. & Bishop, A. J. R. Correlation AnalyzeR: functional predictions from gene co-expression correlations. BMC Bioinform. 22, 206 (2021).","journal-title":"BMC Bioinform."},{"key":"2170_CR52","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.abf6446","volume":"371","author":"JL Hope","year":"2021","unstructured":"Hope, J. L. & Bradley, L. M. Lessons in antiviral immunity. Science 371, 464\u2013465 (2021).","journal-title":"Science"},{"key":"2170_CR53","doi-asserted-by":"publisher","unstructured":"Reyneveld, G. I., Savelkoul, H. F. J. & Parmentier, H. K. Current understanding of natural antibodies and exploring the possibilities of modulation using veterinary models. A review. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.02139 (2020).","DOI":"10.3389\/fimmu.2020.02139"},{"key":"2170_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4049\/jimmunol.1400844","volume":"194","author":"S Panda","year":"2015","unstructured":"Panda, S. & Ding, J. L. Natural antibodies bridge innate and adaptive immunity. J. Immunol. 194, 13\u201320 (2015).","journal-title":"J. Immunol."},{"key":"2170_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.coviro.2013.05.004","volume":"3","author":"F Zabel","year":"2013","unstructured":"Zabel, F., K\u00fcndig, T. M. & Bachmann, M. F. Virus-induced humoral immunity: on how B cell responses are initiated. Curr. Opin. Virol. 3, 357\u2013362 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"2170_CR56","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.cell.2022.02.012","volume":"185","author":"RD Mazor","year":"2022","unstructured":"Mazor, R. D. et al. Tumor-reactive antibodies evolve from non-binding and autoreactive precursors. Cell 185, 1208\u20131222.e1221 (2022).","journal-title":"Cell"},{"key":"2170_CR57","doi-asserted-by":"publisher","first-page":"e1009708","DOI":"10.1371\/journal.ppat.1009708","volume":"17","author":"V Upasani","year":"2021","unstructured":"Upasani, V., Rodenhuis-Zybert, I. & Cantaert, T. Antibody-independent functions of B cells during viral infections. PLoS Pathog. 17, e1009708 (2021).","journal-title":"PLoS Pathog."},{"key":"2170_CR58","doi-asserted-by":"publisher","unstructured":"Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P. & Nelson, B. H. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/s41568-022-00466-1 (2022).","DOI":"10.1038\/s41568-022-00466-1"},{"key":"2170_CR59","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561\u2013565 (2020).","journal-title":"Nature"},{"key":"2170_CR60","doi-asserted-by":"publisher","first-page":"9997","DOI":"10.1128\/JVI.00883-13","volume":"87","author":"T Kimura","year":"2013","unstructured":"Kimura, T. et al. Ifit1 inhibits Japanese encephalitis virus replication through binding to 5\u2032 capped 2\u2032-O unmethylated RNA. J. Virol. 87, 9997\u201310003 (2013).","journal-title":"J. Virol."},{"key":"2170_CR61","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ni.2048","volume":"12","author":"A Pichlmair","year":"2011","unstructured":"Pichlmair, A. et al. IFIT1 is an antiviral protein that recognizes 5\u2032-triphosphate RNA. Nat. Immunol. 12, 624\u2013630 (2011).","journal-title":"Nat. Immunol."},{"key":"2170_CR62","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1093\/nar\/gkt1321","volume":"42","author":"P Kumar","year":"2014","unstructured":"Kumar, P. et al. Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5\u2032-terminal regions of cap0-, cap1- and 5\u2032ppp- mRNAs. Nucleic Acids Res. 42, 3228\u20133245 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2170_CR63","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.virol.2015.01.019","volume":"479\u2013480","author":"JL Hyde","year":"2015","unstructured":"Hyde, J. L. & Diamond, M. S. Innate immune restriction and antagonism of viral RNA lacking 2\u2032-O methylation. Virology 479\u2013480, 66\u201374 (2015).","journal-title":"Virology"},{"key":"2170_CR64","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ccell.2022.03.011","volume":"40","author":"AC Banville","year":"2022","unstructured":"Banville, A. C. & Nelson, B. H. Breaching B cell tolerance in the tumor microenvironment. Cancer Cell 40, 356\u2013358 (2022).","journal-title":"Cancer Cell"},{"key":"2170_CR65","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4049\/jimmunol.1801208","volume":"202","author":"JH Lam","year":"2019","unstructured":"Lam, J. H. & Baumgarth, N. The multifaceted B cell response to influenza virus. J. Immunol. 202, 351\u2013359 (2019).","journal-title":"J. Immunol."},{"key":"2170_CR66","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.tibs.2021.02.002","volume":"46","author":"J Quin","year":"2021","unstructured":"Quin, J. et al. ADAR RNA modifications, the epitranscriptome and innate immunity. Trends Biochem. Sci. 46, 758\u2013771 (2021).","journal-title":"Trends Biochem. Sci."},{"key":"2170_CR67","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.molcel.2019.02.021","volume":"73","author":"A Bhate","year":"2019","unstructured":"Bhate, A., Sun, T. & Li, J. B. ADAR1: a new target for immuno-oncology therapy. Mol. Cell 73, 866\u2013868 (2019).","journal-title":"Mol. Cell"},{"key":"2170_CR68","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1007\/s00262-022-03191-8","volume":"71","author":"V Moreno","year":"2022","unstructured":"Moreno, V. et al. Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies. Cancer Immunol. Immunother. 71, 2985\u20132998 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"2170_CR69","doi-asserted-by":"publisher","first-page":"71002","DOI":"10.18632\/oncotarget.20238","volume":"8","author":"SM Brunner","year":"2017","unstructured":"Brunner, S. M. et al. Tumor-infiltrating B cells producing antitumor active immunoglobulins in resected HCC prolong patient survival. Oncotarget 8, 71002\u201371011 (2017).","journal-title":"Oncotarget"},{"key":"2170_CR70","unstructured":"Delano, W. L. The PyMOL Molecular Graphics System (DeLano Scientific, 2002)."}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41565-026-02170-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-026-02170-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-026-02170-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:06:03Z","timestamp":1782302763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-026-02170-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2170"],"URL":"https:\/\/doi.org\/10.1038\/s41565-026-02170-9","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"19 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B., R.F., E.G., P.S.-S., R.M. and S.S. hold equity and consult in Alyssum Therapeutics. N.G., A. Sengupta, A. Sarkar, R.F. and S.S. are listed as inventors on patents covering AT-1965 licensed to Alyssum Therapeutics. L.G. is a PI on a clinical study funded by Alyssum Therapeutics. I.S.P., T.S., B.S., A.K. and V.S.M. declare no competing interests. H.L.J. is a founder and has a financial interest in Qilin Bio Inc. H.L.J.\u2019s interests were reviewed and are managed by Brigham and Women\u2019s Hospital and Mass General Brigham in accordance with their conflict of interest policies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}